206 related articles for article (PubMed ID: 9347277)
21. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
Deneer VH; Borgh MB; Kingma JH; Lie-A-Huen L; Brouwers JR
Pharm World Sci; 2004 Apr; 26(2):66-78. PubMed ID: 15085940
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
Balla I; Petrela E; Kondili A
Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
[TBL] [Abstract][Full Text] [Related]
23. Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fibrillation.
Botto GL; Bonini W; Broffoni T; Espureo M; Cappelletti G; Lombardi R; Molteni S; Pedraglio E; Ferrari G
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2480-4. PubMed ID: 9825371
[TBL] [Abstract][Full Text] [Related]
24. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
Lee SH; Chen SA; Chiang CE; Tai CT; Wen ZC; Wang SP; Chang MS
J Intern Med; 1996 Mar; 239(3):253-60. PubMed ID: 8772625
[TBL] [Abstract][Full Text] [Related]
25. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm.
Capucci A; Boriani G; Rubino I; Della Casa S; Sanguinetti M; Magnani B
Int J Cardiol; 1994 Mar; 43(3):305-13. PubMed ID: 8181888
[TBL] [Abstract][Full Text] [Related]
26. [A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].
Satullo G; Arrigo F; Cavallaro L; Coglitore A; Fazio F; Saporito F; Sorrenti S; Oreto G
Minerva Cardioangiol; 1996 Mar; 44(3):141-4. PubMed ID: 8767614
[TBL] [Abstract][Full Text] [Related]
27. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
[TBL] [Abstract][Full Text] [Related]
28. Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?
Botto GL; Bonini W; Broffoni T; Molteni S; Lombardi R; Alfieri G; Barone P; Bernasconi G; Ferrari G
Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1939-43. PubMed ID: 8945073
[TBL] [Abstract][Full Text] [Related]
29. Predictors of success in the conversion of new-onset atrial fibrillation using oral propafenone.
Ergene U; Ergene O; Cete Y; Fowler J; Nazli C; Oktay C
Eur J Emerg Med; 1998 Dec; 5(4):425-8. PubMed ID: 9919447
[TBL] [Abstract][Full Text] [Related]
30. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation.
Khan IA
J Am Coll Cardiol; 2001 Feb; 37(2):542-7. PubMed ID: 11216976
[TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
Piccini JP; Pritchett EL; Davison BA; Cotter G; Wiener LE; Koch G; Feld G; Waldo A; van Gelder IC; Camm AJ; Kowey PR; Iwashita J; Dittrich HC
Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936
[TBL] [Abstract][Full Text] [Related]
32. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
33. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
Martínez-Marcos FJ; García-Garmendia JL; Ortega-Carpio A; Fernández-Gómez JM; Santos JM; Camacho C
Am J Cardiol; 2000 Nov; 86(9):950-3. PubMed ID: 11053705
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacological cardioversion of atrial fibrillation with intravenous and oral propafenone].
Peciuliene I; Lukoseviciūte A
Medicina (Kaunas); 2002; 38(12):1212-6. PubMed ID: 12552163
[TBL] [Abstract][Full Text] [Related]
35. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
Dogan A; Ergene O; Nazli C; Kinay O; Altinbas A; Ucarci Y; Ergene U; Ozaydin M; Gedikli O
Acta Cardiol; 2004 Jun; 59(3):255-61. PubMed ID: 15255456
[TBL] [Abstract][Full Text] [Related]
37. Management of patients with acute atrial fibrillation in the ED.
Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
[TBL] [Abstract][Full Text] [Related]
38. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.
Lee SH; Chen SA; Tai CT; Chiang CE; Wen ZC; Chen YJ; Yu WC; Huang JL; Fong AN; Cheng JJ; Chang MS
Am J Cardiol; 1997 Apr; 79(7):905-8. PubMed ID: 9104904
[TBL] [Abstract][Full Text] [Related]
39. [Propafenone dose for emergency room conversion of paroxysmal atrial fibrillation].
Antonelli D; Darawsha A; Rimbrot S; Freedberg NA; Rosenfeld T
Harefuah; 1999 Jun; 136(11):857-9, 915. PubMed ID: 10955129
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of intravenous and per os propafenone in the ambulatory treatment of recent-onset atrial fibrillation].
Margheri M; Fradella G; Maioli M; Paterni M; Bartoli P; Bonechi F; Brandinelli A; Mazza F; Sansoni M; Zipoli A
G Ital Cardiol; 1992 Mar; 22(3):257-65. PubMed ID: 1426770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
